Terug
36
Ook genoteerd als
CJEWY
OTC
Dagbereik
€ 1,90
€ 1,90
52-Weeksbereik
€ 0,92
€ 2,17
Volume
300
50D / 200D Gem.
€ 1,77
/
€ 1,72
Vorige Slotkoers
€ 1,90
Koershistorie
Financiële Trends
Sectorvergelijking
vs Consumer Cyclical sector mediaan (610 peers)
| Metriek | Aandeel | Sector Mediaan |
|---|---|---|
| P/E | 3,2 | 11,1 |
| P/B | 0,7 | 1,4 |
| ROE % | 22,7 | 10,7 |
| Net Margin % | 6,6 | 5,2 |
| Rev Growth 5Y % | 6,3 | 8,1 |
| D/E | 0,8 | 0,8 |
Koersdoel Analisten
Geen analistendekking beschikbaar
Winstschattingen
| Periode | WPA Sch. | Omzet Sch. | Analisten |
|---|---|---|---|
| FY2028 |
€ 1,09
€ 1,04 – € 1,13
|
100 B | 1 |
| FY2027 |
€ 0,99
€ 0,95 – € 1,03
|
97 B | 1 |
| FY2026 |
€ 0,88
€ 0,84 – € 0,92
|
94 B | 1 |
Belangrijkste Punten
Revenue grew 6,32% annually over 5 years — modest growth
ROE of 22,69% indicates high profitability
Generating 9,68B in free cash flow
P/E of 3,17 — trading at a low valuation
Revenue growth is decelerating — 1Y growth trails 5Y average by 23,85%
Cash machine — converts 163,58% of earnings into free cash flow
Groei
Revenue Growth (5Y)
6,32%
Revenue (1Y)-17,53%
Earnings (1Y)-8,98%
FCF Growth (3Y)9,41%
Kwaliteit
Return on Equity
22,69%
ROIC22,42%
Net Margin6,60%
Op. Margin15,74%
Veiligheid
Debt / Equity
0,79
Current Ratio1,40
Interest Coverage23,81
Waardering
P/E Ratio
3,17
P/B Ratio0,71
EV/EBITDA2,26
Dividend Yield0,07%
All Fundamental Metrics
| Growth | |||
| Revenue Growth (1Y) | -17,53% | Revenue Growth (3Y) | -2,69% |
| Earnings Growth (1Y) | -8,98% | Earnings Growth (3Y) | 4,82% |
| Revenue Growth (5Y) | 6,32% | Earnings Growth (5Y) | -0,46% |
| Profitability | |||
| Revenue (TTM) | 89,66B | Net Income (TTM) | 5,92B |
| ROE | 22,69% | ROA | 7,73% |
| Gross Margin | 29,51% | Operating Margin | 15,74% |
| Net Margin | 6,60% | Free Cash Flow (TTM) | 9,68B |
| ROIC | 22,42% | FCF Growth (3Y) | 9,41% |
| Safety | |||
| Debt / Equity | 0,79 | Current Ratio | 1,40 |
| Interest Coverage | 23,81 | Dividend Yield | 0,07% |
| Valuation | |||
| P/E Ratio | 3,17 | P/B Ratio | 0,71 |
| P/S Ratio | 0,21 | PEG Ratio | -1,31 |
| EV/EBITDA | 2,26 | Dividend Yield | 0,07% |
| Market Cap | 18,74B | Enterprise Value | 31,95B |
Income Statement
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Revenue | 89,66B | 108,71B | 94,68B | 98,94B | 70,16B |
| Net Income | 5,92B | 6,50B | 5,38B | 6,71B | 6,03B |
| EPS (Diluted) | 0,59 | 0,65 | 0,54 | 0,67 | 0,60 |
| Gross Profit | 26,45B | 22,29B | 21,17B | 22,34B | 20,07B |
| Operating Income | 14,12B | 9,09B | 8,06B | 9,34B | 9,07B |
Balance Sheet
Annual, most recent first
| Metric | FY2025 | FY2024 | FY2023 | FY2022 | FY2021 |
|---|---|---|---|---|---|
| Total Assets | 76,52B | 88,82B | 87,34B | 87,74B | 64,31B |
| Total Liabilities | 49,13B | 62,07B | 53,98B | 53,18B | 32,74B |
| Shareholders' Equity | 26,43B | 25,72B | 32,40B | 33,62B | 30,77B |
| Total Debt | 20,79B | 29,89B | 22,11B | 25,98B | 13,64B |
| Cash & Equivalents | 7,58B | 7,70B | 11,70B | 14,94B | 6,03B |
| Current Assets | 67,27B | 79,18B | 77,27B | 78,13B | 55,24B |
| Current Liabilities | 48,13B | 57,52B | 51,02B | 49,63B | 29,14B |
Strategiescores
This stock passed the criteria for 1 strategy
Score = fit strength (0–100)
Rank = position among all matches
#268 of 670
Recente Activiteit
Ingestapt
Contrarian Investing (David Dreman)
Mar 24, 2026